Anti-platelets in diabetes management

Internal Medicine Journal
N M GranthamJ E Shaw

Abstract

This study aimed to determine the prevalence of anti-platelet use, and the extent to which contraindications to anti-platelet therapy prevent its use, in 726 diabetic patients attending a private clinic. Among those who reported a history of cardiovascular disease (CVD), 87.1% were on anti-platelet therapy. Of those without prior CVD but with at least one CVD risk factor, 59.8% were not on anti-platelet therapy, but only 7.1% of these had a contraindication to anti-platelet therapy. This study showed that high usage of anti-platelet therapy in diabetic patients with prior CVD is achievable, and that contraindications did not explain low use in those without prior CVD.

References

Aug 13, 1999·Diabetic Medicine : a Journal of the British Diabetic Association·D M WoodP G Colman
Dec 25, 2003·Diabetes Care·John A Colwell, UNKNOWN American Diabetes Association
Dec 25, 2003·Diabetes Care·Mark E MolitchUNKNOWN American Diabetes Association
Apr 28, 2004·Clinical Therapeutics·Jennifer A KlinkeSumit R Majumdar
Dec 15, 2004·Archives of Internal Medicine·Stephen D Persell, David W Baker
May 6, 2005·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·Alberto BrunoGianfranco Pagano
Jun 10, 2005·Acta Diabetologica·S Fateh-MoghadamW Bocksch
Oct 6, 2005·Current Opinion in Nephrology and Hypertension·Paul E de Jong, Ron T Gansevoort
Dec 3, 2005·Cardiovascular Diabetology·Shaun R MillerCharles D MacLean
Sep 21, 2006·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·UNKNOWN ACE/ADA Task Force on Inpatient Diabetes
Jan 16, 2007·Arquivos brasileiros de endocrinologia e metabologia·Cristiane B LeitãoLuis H Canani
Apr 21, 2007·European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology·Anette E BuykenGerd Assmann
Nov 11, 2008·JAMA : the Journal of the American Medical Association·Hisao OgawaUNKNOWN Japanese Primary Prevention of Atherosclerosis With Aspirin for Diabetes (JPAD) Trial Investigators

❮ Previous
Next ❯

Citations

Feb 22, 2013·EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·Javier EscanedCarlos Macaya

❮ Previous
Next ❯

Related Concepts

Related Feeds

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.